David Rosa - Intuitive Surgical Chief Commercial Officer and Executive VP
| ISRG Stock | USD 538.55 3.55 0.65% |
EVP
Mr. David J. Rosa is Executive Vice President, Chief Commercial Officer of the Company. Mr. Rosa joined Intuitive Surgical in March 1996 and has held leadership positions in engineering, clinical development, marketing and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures Technology and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. Prior to joining Intuitive Surgical, Mr. Rosa contributed to the development of transesophageal transducers for Acuson Corporationrationration. Mr. Rosa also currently serves on the boards of directors of Kardium Inc. and Arterys Inc since 2015.
| Age | 56 |
| Tenure | 9 years |
| Phone | 408 523 2100 |
| Web | https://www.intuitive.com |
David Rosa Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Rosa against Intuitive Surgical stock is an integral part of due diligence when investing in Intuitive Surgical. David Rosa insider activity provides valuable insight into whether Intuitive Surgical is net buyers or sellers over its current business cycle. Note, Intuitive Surgical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Intuitive Surgical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Rosa over a year ago Acquisition by David Rosa of 75930 shares of Biotricity subject to Rule 16b-3 |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0795 % which means that it generated a profit of $0.0795 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1597 %, meaning that it created $0.1597 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0795 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Chief Commercial Officer and Executive VP | ||
| Mark Brosius, Senior Officer | ||
| Ian Purdy, Senior Assurance | ||
| Julian Nikolchev, Sr Strategy | ||
| Gillian EdD, Senior ServicesWorldwide | ||
| Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
| Gary JD, General VP | ||
| Gary Loeb, G Officer | ||
| Robert DeSantis, Executive Officer | ||
| Brian King, Treasurer VP | ||
| Gary Guthart, CEO and President and Director | ||
| Marc Bland, GM VP | ||
| Philip Kim, Head Relations | ||
| MD FACS, Executive Officer | ||
| Glenn Vavoso, Senior APAC | ||
| Brian Miller, Executive Officer | ||
| Patricia Wadors, Chief Officer | ||
| Henry Charlton, Senior Officer | ||
| Fredrik Widman, Principal VP | ||
| Marshall Mohr, Executive Services | ||
| Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0795 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.28 % | ||||
| Current Valuation | 188.85 B | ||||
| Shares Outstanding | 356.18 M | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 89.16 % | ||||
| Number Of Shares Shorted | 3.85 M | ||||
| Price To Earning | 69.96 X |
Currently Active Assets on Macroaxis
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.